Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Go back to Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial ResultsAcorda Therapeutics, Inc. (NASDAQ: ACOR) | Delayed: 0.66 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.66 | 52 Week High | $43.63 | |||
Open | $0.66 | 52 Week Low | $16.40 | |||
Day High | $0.66 | P/E | 1.69 | |||
Day Low | $0.66 | EPS | $0.39 | |||
Volume | 109,339 |